Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Voorwerk, Leonie; Slagter, Maarten; Horlings, Hugo M; Sikorska, Karolina; van de Vijver, Koen K; de Maaker, Michiel; Nederlof, Iris; Kluin, Roelof J C; Warren, Sarah; Ong, SuFey; Wiersma, Terry G; Russell, Nicola S; Lalezari, Ferry; Schouten, Philip C; Bakker, Noor A M; Ketelaars, Steven L C; Peters, Dennis; Lange, Charlotte A H; van Werkhoven, Erik; van Tinteren, Harm; Mandjes, Ingrid A M; Kemper, Inge; Onderwater, Suzanne; Chalabi, Myriam; Wilgenhof, Sofie; Haanen, John B A G; Salgado, Roberto; de Visser, Karin E; Sonke, Gabe S; Wessels, Lodewyk F A; Linn, Sabine C; Schumacher, Ton N; Blank, Christian U; Kok, Marleen

Voorwerk, Leonie; Slagter, Maarten; Horlings, Hugo M; Sikorska, Karolina; van de Vijver, Koen K; de Maaker, Michiel; Nederlof, Iris; Kluin, Roelof J C; Warren, Sarah; Ong, SuFey; Wiersma, Terry G; Russell, Nicola S; Lalezari, Ferry; Schouten, Philip C; Bakker, Noor A M; Ketelaars, Steven L C; Peters, Dennis; Lange, Charlotte A H; van Werkhoven, Erik; van Tinteren, Harm; Mandjes, Ingrid A M; Kemper, Inge; Onderwater, Suzanne; Chalabi, Myriam; Wilgenhof, Sofie; Haanen, John B A G; Salgado, Roberto; de Visser, Karin E; Sonke, Gabe S; Wessels, Lodewyk F A; Linn, Sabine C; Schumacher, Ton N; Blank, Christian U; Kok, Marleen.

Afiliação

Voorwerk L; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Slagter M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Horlings HM; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sikorska K; Oncode Institute, Utrecht, the Netherlands.
van de Vijver KK; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
de Maaker M; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Nederlof I; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Kluin RJC; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
Warren S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ong S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Wiersma TG; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Russell NS; NanoString Technologies, Inc, Seattle, WA, USA.
Lalezari F; NanoString Technologies, Inc, Seattle, WA, USA.
Schouten PC; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Bakker NAM; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ketelaars SLC; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Peters D; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Lange CAH; Oncode Institute, Utrecht, the Netherlands.
van Werkhoven E; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
van Tinteren H; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Mandjes IAM; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Kemper I; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Onderwater S; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Chalabi M; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Wilgenhof S; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Haanen JBAG; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Salgado R; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
de Visser KE; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sonke GS; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Wessels LFA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Linn SC; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Schumacher TN; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Blank CU; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.
Kok M; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia.

Nat Med ; 25(7): 1175, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31209337

RESUMO

In the version of this article originally published, there was an error in Fig. 3j. A label on the heatmap read "TGF-α signaling via NF-κB". It should have read "TNF-α signaling via NF-κB". The error has been corrected in the HTML and PDF versions of this article.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google